RVU120 (SEL120) clinical trials

RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms

This study is testing a new drug, RVU120, for people with a blood condition called lower-risk myelodysplastic syndrome (MDS) who have anaemia. We want to see if RVU120 can help improve their red blood cell count and if it's safe to use.